Tuesday, September 26 | 9am-Noon
This workshop will examine FDA’s years-long court battle over the legality of DMAA, regulatory strategies to establish the safety of a new ingredient, an update on class action litigation, and tips to defend against lawsuits brought by regulators and the private plaintiffs’ bar.
Join us to unearth:
- The status of FDA’s DMAA court case, and its implications, for the dietary supplement industry;
- The pros and cons of a new dietary ingredient notification (NDIN) vs. self-affirmed GRAS (generally recognized as safe);
- Trends in class action lawsuits; and
- Strategies in mounting a defense in response to lawsuits filed by the government and private plaintiffs.